Coronavirus vaccine update: Covid drug, AstraZeneca vaccine current status
The total number of coronavirus cases across the world has
now crossed the 7-million mark. A little more than five months have passed
since the world first learnt of the deadly SARS-CoV-2 infection. Since then,
researchers are scrambling to produce vaccine and also to repurpose existing
treatments to help fight the uncontrollable virus. According to the World Health Organization (WHO), there
are move than 115 teams speeding up efforts to produce a vaccine or an
effective drug for Covid-19 treatment. Major pharmaceutical companies such as
Gilead Sciences, AstraZeneca, Pfizer and Moderna are rushing to find a
successful vaccine and some of them have succeeded in many ways.
Coronavirus treatment: Here are updates
on coronavirus vaccine/drug development:
1. Coronavirus vaccine: AstraZeneca
approaches Gilead over possible merger
AstraZeneca
approached one of its US rivals, Gilead Sciences, last month over a potential
merger, Bloomberg has
reported.
A
transatlantic tie-up would be the biggest healthcare merger yet, forging a
company worth around 200 billion pounds, and bringing together firms leading
the pharmaceutical industry’s efforts to develop a vaccine and treatments for
Covid-19.
Comments
Post a Comment